Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.
2.

High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome.

Li Q, Meng X, Liang L, Xu Y, Cai G, Cai S.

Am J Cancer Res. 2015 Aug 15;5(9):2856-64. eCollection 2015.

3.

Rectal cancer: a review.

Fazeli MS, Keramati MR.

Med J Islam Repub Iran. 2015 Jan 31;29:171. eCollection 2015. Review.

4.

Hospital variation in sphincter preservation for elderly rectal cancer patients.

Dodgion CM, Neville BA, Lipsitz SR, Schrag D, Breen E, Zinner MJ, Greenberg CC.

J Surg Res. 2014 Sep;191(1):161-8. doi: 10.1016/j.jss.2014.03.047. Epub 2014 Mar 22.

5.

What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer.

Lee WS, Lee SH, Baek JH, Lee WK, Lee JN, Kim NR, Park YH.

Radiat Oncol. 2013 Aug 19;8:202. doi: 10.1186/1748-717X-8-202.

6.

Development and progression of colorectal neoplasia.

Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE.

Cancer Biomark. 2010;9(1-6):235-65. doi: 10.3233/CBM-2011-0160. Review.

7.

Metastatic colorectal cancer to a primary thyroid cancer.

Cherk MH, Moore M, Serpell J, Swain S, Topliss DJ.

World J Surg Oncol. 2008 Nov 11;6:122. doi: 10.1186/1477-7819-6-122.

8.

The effect of hospital and surgeon volume on outcomes for rectal cancer surgery.

Salz T, Sandler RS.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1185-93. doi: 10.1016/j.cgh.2008.05.023. Epub 2008 Oct 1. Review.

10.

Rectal cancer in Luxembourg : a national population-based data report, 1988-1998.

Scheiden R, Sand J, Weber J, Turk P, Wagener Y, Capesius C.

BMC Cancer. 2003 Oct 21;3:27.

Supplemental Content

Support Center